GLP-1 , which is discussed in more detail here, slows gastric emptying, increases feelings of fullness, and helps regulate blood sugar levels after meals
Decades of research have found that it can help people drink less, reduce heavy drinking days, and lower the risk of returning to heavy drinking after theyve cut back or stopped
This important pharmacokinetic characteristic of the drug was not considered in the 2001 trial design
Yu H, Sun T, He X, Wang Z, Zhao K, An J, et al
Collectively, the duo dominate the sector and appear likely to do so for the near future, despite a rush of competitors racing to get drugs to market, and they are facing mounting pressure to ramp up production